(E)-3-(6-Amino-3-chloro-2-fluorophenyl)acrylic acid, 98%, 50mg

(1R,3S)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)cyclopentanecarboxylic acid, 95.0%, 1g

(3R)-3-(Bromomethyl)-2,3-dihydro-1,4-benzodioxine, 97%, 1g

2-(2,6-Difluoro-4-isopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95%, 250mg

2-Octylbenzimidazole, 97.0%, 100g

(R)-1-(3,4-DIFLUOROPHENYL)ETHAN-1-OL, 95%, 10g

Capillaire à point de fusion, 80 mm, 1,00 mm, 0,80 mm, 1000 pièce(s)

2-Chloro-N-methoxy-N-methylbenzamide, 95.0%, 1g

3,6,9,12,15,18,21-Heptaoxatricosane-1,23-diamine, 95%, 10g

(3aR,6S)-8,8-Dimethyl-4,5,6,7-tetrahydro-3H-3a,6-methanobenzo[c]isothiazole 2,2-dioxide, 95.0%, 25g

2-(3,4-Difluorophenyl)-2-methyloxirane, 98%, 2.5g

2-Chloro-4-nitroanisole, 98.0%, 100g

Methyl (S)-2-((tert-butoxycarbonyl)amino)-3-((S)-2-oxopyrrolidin-3-yl)propanoate, 95%, 100g